Voss Value-Oriented Special Situations Fund, LP, 10% Owner at Rein Therapeutics, Inc. (RNTX), bought 577,084 shares at $1.37 ($798K) on 2025-10-27, disclosed to the SEC on 2025-10-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.39 | 30,176 | $42K | 5.3% |
| 2 | $1.37 | 4,840 | $7K | 0.8% |
| 3 | $1.37 | 92,642 | $127K | 15.9% |
| 4 | $1.37 | 92,642 | $127K | 15.9% |
| 5 | $1.39 | 178,392 | $248K | 31.1% |
| 6 | $1.39 | 178,392 |
| $248K |
| 31.1% |
| Total | $1.38 avg | 577,084 | $798K | 100% |
| Filing → |